CBD Industries, LLC, the wholly owned manufacturing and
distribution subsidiary of cbdMD, Inc., a nationally recognized
consumer cannabidiol (CBD) brand (NYSE American: YCBD, YCBD PR A),
was recently added to NSF International’s dietary supplements Good
Manufacturing Practice (GMP) registration. GMPs are guidelines that
provide a system of processes, procedures and documentation to
assure a product has the identity, strength, composition, quality
and purity that appear on its label. In September 2019 NSF
International announced it had begun providing a wide variety of
independent testing, verification, auditing and certification
services to manufacturers of consumer products containing hemp and
hemp-derived CBD. NSF International independently registers
manufacturers as meeting GMP requirements.
cbdMD produces a comprehensive line of hemp extracted,
THC-free*1 CBD products including tinctures, capsules, gummies,
topicals, bath bombs, and pet products. The company maintains
manufacturing, warehousing, and office facilities in Charlotte,
North Carolina.
“As a company who has been committed to following GMP from the
start, obtaining the NSF GMP registration proves cbdMD is setting a
new standard for trust in a product market where it is needed,”
said Scott Coffman, Co-CEO of cbdMD. “Along with our Superior Broad
Spectrum formulations, we believe that achieving the difficult to
attain NSF GMP registration sets the company apart from the
competition and tells consumers that cbdMD provides consistent
quality for those seeking reliable, unadulterated hemp-derived
broad spectrum and CBD products.”
GMP registration from NSF International may also provide
guidance for major retailers while regulators decide how to best
protect consumers of hemp-derived supplements.
“In the current landscape, big box retailers and many other
sellers require objective assurance that hemp supplements meet the
U.S. GMP requirements,” Coffman continued. “NSF GMP registration
further demonstrates our commitment to that goal.”
The NSF International’s GMPs were developed in accordance with
the U.S. Food and Drug Administration’s (FDA) 21 CFR part 111
regulation on dietary supplement manufacturing, packaging, and
distribution. Utilizing GMP guidelines assists companies in
developing and maintaining proper controls in their manufacturing
process so that products are processed, manufactured and labeled in
a consistent manner, and meet quality standards.
“The GMP mark indicates that an NSF International auditor has
entered a facility, reviewed relevant documents and processes, and
deemed the facility compliant with GMP regulations for production,”
said David Trosin, Managing Director, Health Sciences Certification
at NSF International. “We’re very pleased to grant NSF GMP
registration to cbdMD’s manufacturing facility.”
cbdMD will begin leveraging the NSF GMP Registration mark across
the company’s websites and applicable marketing collateral
immediately.
cbdMD’s Superior Broad Spectrum CBD products are available to
consumers at the company’s retail website, www.cbdMD.com.
New wholesale customers can make inquiries through the cbdMD
wholesale page. Current wholesale account holders may make
purchases through regular channels.
About cbdMD
cbdMD, Inc. is a nationally recognized consumer cannabidiol
(CBD) brand whose current products include CBD tinctures, CBD
capsules, CBD gummies, CBD topicals, CBD bath bombs, and CBD pet
products. cbdMD is also a proud partner of Bellator MMA, Life Time,
Inc., and Supercross, and has one of the largest rosters of
professional sports athletes who are part of “Team cbdMD.” To learn
more about cbdMD and our comprehensive line of over 100 SKUs of
U.S. produced, THC-free CBD products, please visit www.cbdMD.com,
follow cbdMD on Instagram and Facebook, or visit one of the 4,000
retail outlets that carry cbdMD products.
About NSF International
NSF International is a global public health organization that
facilitates new language standards and tests and certifies products
for the water, food, health sciences, and consumer goods industries
to minimize adverse health effects and protect the environment.
Founded in 1944, NSF is committed to protecting human health and
safety worldwide. With operations in more than 175 countries, NSF
International is a Pan American Health Organization/World Health
Organization (WHO) Collaborating Center on Food Safety, Water
Quality and Indoor Environment.
Forward-Looking Statements
This press release contains certain forward-looking statements
that are based upon current expectations and involve certain risks
and uncertainties within the meaning of the U.S. Private Securities
Litigation Reform Act of 1995. Such forward-looking statements can
be identified by the use of words such as ″should,″ ″may,″
″intends,″ ″anticipates,″ ″believes,″ ″estimates,″ ″projects,″
″forecasts,″ ″expects,″ ″plans,″ and ″proposes.″ These
forward-looking statements are not guarantees of future performance
and are subject to risks, uncertainties, and other factors, some of
which are beyond our control and difficult to predict and could
cause actual results to differ materially from those expressed or
forecasted in the forward-looking statements. You are urged to
carefully review and consider any cautionary statements and other
disclosures, including the statements made under the heading "Risk
Factors" in cbdMD, Inc.'s Annual Report on Form 10-K for the fiscal
year ended September 30, 2019, as filed with the Securities and
Exchange Commission (the "SEC"), and our other filings with the
SEC. All forward-looking statements involve significant risks and
uncertainties that could cause actual results to differ materially
from those in the forward-looking statements, many of which are
generally outside the control of cbdMD, Inc. and are difficult to
predict. cbdMD, Inc. does not undertake any duty to update any
forward-looking statements except as may be required by law. The
information which appears on our websites and our social media
platforms, including, but not limited to, Instagram and Facebook,
is not part of this press release.
1 THC-free is defined as below the level of detection using
valid scientific analytical tools.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200413005097/en/
cbdMD PR PR@cbdMD.com 1 (800) 973-3984
Investors: John Weston john.weston@cbdMD.com 704-249-9515
cbdMD (AMEX:YCBD)
Historical Stock Chart
From Apr 2024 to May 2024
cbdMD (AMEX:YCBD)
Historical Stock Chart
From May 2023 to May 2024